
Amanda Fader, MD
GynecologyGynecologic Oncology
Highlights
Age Groups Seen
- Infant 0-2
- Child 3-12
- Adolescent 13-17
- Young Adult 18-25
- Adult 26-64
- Older Adult 65+
Languages
- Spanish
- English
In-Network Plans
View All Accepted Plans (12)Gender
FemaleJohns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Amanda Fader
Professional Titles
- Vice Chair of Gynecologic Surgical Operations, Johns Hopkins Health System
- Director, Center for Rare Gynecologic Cancers
Primary Academic Title
Professor of Gynecology and Obstetrics
Johns Hopkins Physician
Background
Dr. Amanda Nickles Fader is a professor in the Johns Hopkins Hospital Department of Gynecology and Obstetrics and the Sidney Kimmel Cancer Center. She is the former fellowship director and division director of the Johns Hopkins Kelly Gynecologic Oncology Service and currently is Vice Chair of Gynecologic Surgical Operations and the Director of the Center for Rare Gynecologic Cancers. Additionally, she serves as the 2024-2025 President of the Society of Gynecologic Oncology.
Dr. Fader received her undergraduate degree with highest distinction in music (violin performance) and pre-medicine from the University of Virginia. She earned her medical degree from the Medical College of Virginia, and completed her residency in obstetrics and gynecology at the Magee-Women’s Hospital of UPMC in Pittsburgh. Dr. Fader then underwent gynecologic oncology fellowship training at the Cleveland Clinic. She has co-authored more than 230 publications in peer-reviewed medical journals and is recognized as an expert in rare gynecologic tumors, clinical trials and quality and safety in surgery. She has a special interest in uterine serous carcinoma and low-grade serous carcinoma of the ovary and currently serves as the PI or co-PI of three international NRG Oncology clinical trials.
Dr. Fader serves as a national board examiner in gynecologic oncology for the American Board of Obstetrics and Gynecology and Associate Editor of the Gynecologic Oncology journal is a member of the Rare Tumor and Uterine Corpus Committees of the NRG/Gynecologic Oncology Group. She is also co-founder of the Society of Gynecologic Oncology BRIDGES Program, a two-year longitudinal clinical trials and career development program for early-career oncologists. She has been the recipient of several research grants and awards for her research, including the Society of Gynecologic Oncology Innovations Award, the Best AAGL Paper in Minimally Invasive Gynecologic Oncology Surgery, a Department of Defense Ovarian Cancer Clinical Trials Academy Leadership Award, and National Cancer Institute Cervical SPORE grant.
Dr. Fader is consistently recognized for clinical excellence on lists such as Baltimore magazine’s Top Docs and Castle Connolly’s Top Doctors, and is a recipient of the Top 10 Docs, Compassionate Doctors and Patient Choice Awards from Vitals.com. She has particular expertise with the surgical and medical management of uterine (endometrial), ovarian, cervical and vulvar cancers, as well as the treatment of women who are at high risk for developing a gynecologic malignancy. She has a special interest in caring for patients throughout the entire spectrum of their lives: from preventive oncology — minimizing key risk factors that can lead to gynecologic cancers — to survivorship initiatives addressing all aspects of recovery, including emotional well-being, sexual health and clinical follow-up.
Clinical Trial Keywords
Phase 1 Investigator Initiated Trials; National Cancer Institute; Gynecologic Oncology Group
Find a Clinical Trial
View all trials by this principal investigator.
Videos
Recent News Articles and Media Coverage
- New Protocols Protect Patients from Surgical Complications, Johns Hopkins Gynecology & Obstetrics Newsletter (Winter 2018)
- Ovarian Cancer: HMT Extends Survival, MedPage Today (06/2016)
- 7 Signs of Ovarian Cancer You May Be Ignoring, Reader's Digest (04/2016)
- Morcellation, Cancer and Loss of Women's Choice, Medscape (03/2016)
- New HPV Vaccine Can Prevent 80% of Cervical Cancers, Yahoo Health (05/2015)
- Genetic Testing for Breast and Ovarian Cancer Risk and Debate over Preventive Surgery, The Diane Rehm Show (03/2015)
- Awareness of Genetics, Ovarian Cancer Link Could Be a Lifesaver, WBAL-TV 11 (07/2013)
- Losing Weight and Lowering Risk: What You Need to Know about Women's Cancer and Nutrition, Recorded online seminar (12/2014)
- Obesity and the Risk for Women's Cancers, Recorded online seminar (10/2013)
Additional Academic Titles
Professor of Oncology
PubMed - Publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=amanda+nickles+fader
Selected Publications
- 1. Tice DA, Biscardi JK, Nickles AL, Parsons SJ. Mechanism of biological synergy between cellular Src and the epidermal growth factor receptor, Proc Nat Acad of Sci, vol. 96, pp1415-1420, Feb 1999
2. Haskell MD, Nickles AL, Dukes B, Parsons SJ, p190RhoGAP: phosphorylation of tyrosine 1105 by c-Src is necessary, but not sufficient, to regulate actin cytoskeletal dynamics in CH310T1/2 fibroblasts, J Cell Sci. 2001 May;114(Pt 9):1699-708
3. Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ, Bristow RE, Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/ progesterone receptors; Cancer, 2003 Oct 15;98(8):1658-63
4. Fader AN, Mansuria S, Guido RS, Weisenfeld H. A 14-week abdominal pregnancy after total abdominal hysterectomy. Obstet Gynecol. 2007 Feb;109(2 Pt2):519-21.
5. Fader AN, Rose PG. Vaginal Metastases from Pancreatic Adenocarcinoma: A Case Report and Review of the Literature. Am J Obstet Gynecol. 2007 Nov;197(5)
6. Axtell AE, Kelley JL, Fader AN, Gupta D, Schwartz B, Gallion HH, Kanbour-Shakir A. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer. Gynecol Oncol. 2007 Dec;107(3):482-6
7. Moore KN, Moxley K, Fader AN, Axtell AE, Rocconi R, Abaid L, Cass IA, Rose PG, Leath CA, Rutledge T, Blankenship D, Gold MA. Serous Fallopian Tube Carcinoma: A Retrospective, Multi-institutional Case Control Comparison to Serous Adenocarcinoma of the Ovary, Gynecol Oncol. 2007 Dec;107(3):398-403
8. Fader AN, Rose PG. Role of Surgery in Ovarian Cancer. J Clin Oncol. 2007 Jul 10;25(20):2873-83
9. Fader AN, von Gruenigen VE, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose PG. Improved tolerance of primary chemotherapy with reduced dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecol Oncol, 2008 Apr;109(1):33-8.
10. Fader AN, Edwards RP, Kanbour A, Cost ML, Kelley J, Comerci J, Sukumvanich P, Schwartz B, Cencia Rohan L. Sentinel Lymph Node Biopsy in Early-Stage Cervical Cancer: Utility of Intraoperative versus Postoperative Assessment. Gynecol Oncol, Oct 2008;111(1):13-17
11. Fader AN, Nagel C, OMalley, DM, Rose PG, Gibbons HE, Huh WK, Havrilesky LJ, Moore KN, Kelley JL, Gehrig P, Tuller E, Axtell AE, Alvarez Secord A, Nagel C, Zanotti KM. Stage II Uterine Papillary Serous Carcinoma: Carboplatin/ Paclitaxel Therapy Improves Recurrence and Survival Outcomes. Gynecol Oncol, March 2009:112(3):558-62.
12. Fader AN, Drake RD, OMalley, DM, Rose PG, Gibbons HE, Huh WK, Havrilesky LJ, Moore, KN, Kelley JL, Gehrig P, Tuller E, Axtell AE, Alvarez Secord A, Nagel C, Zanotti KM, Platinum/taxane-based chemotherapy with or without radiation therapy favorably impact survival outcomes in stage I uterine papillary serous carcinoma. In press, Cancer, May 15;115(10):2119-27.
13. Fader AN, Michener CM, Frasure HE, Giannios N, Belinson JL, Zanotti KM Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes. J Min Inv Gynecol. 2009 May-Jun;16(3):333-9.
14. Fader AN, Starks D, Gehrig PA, Secord AA, Frasure HE, O'Malley DM, Tuller ER, Rose PG, Havrilesky LJ, Moore KN, Huh WK, Axtell AE, Kelley JL, Zanotti KM; UPSC Consortium. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2009 Nov;115(2):244-8.
15. Escobar PF, Fader AN, Paraiso MF, Kaouk JH, Falcone T. Robotic-assisted laparoendoscopic single-site surgery in gynecology: initial report and technique. J Minim Invasive Gynecol. 2009 Sep-Oct;16(5):589-91.
16. Fader AN, Escobar PF. Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report. Gynecol Oncol. 2009 Aug;114(2):157-61.*Chosen as lead article with accompanying editorial by Pedro Ramirez, MD.
17. Fader AN, Rose PG. Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel. Int J Gynecol Cancer. 2009 Oct;19(7):1281-3.
18. Escobar PF, Bedaiwy M, Fader AN, Falcone T. Laparoendoscopic Single-Site (LESS) Surgery in Patients with Benign Adnexal Disease. Fertil and Steril. 2010 Apr;93(6):2074.e7-10.
19. Fader AN, Boruta D, Olawaiye AB, Gehrig PA. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol. 2010 Feb;22(1):21-9.
20. Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol. 2010 Jan;116(1):10-14.
21. Escobar PF, Starks DC, Fader AN, Barber M, Rojas-Espalliat L. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysis. Gynecol Oncol. 2010 Oct;119(1):43-7.
22. Herzog TJ, Krivak TC, Fader AN, Coleman RL. Chemosensitivity testing with ChemoFx and Overall Survival in Primary Ovarian Cancer. Am J Obstet and Gynecol. 2010 Jul;203(1):68.e1-6.
23. Nieves Arriba L, Fader AN, Frasure H, von Gruenigen VE. Quality of Life in Women with Ovarian Cancer. Gynecol Oncol. Nov 2010;119(2):390-6.
24. Fader AN, Rojas-Espaillat L, Ibeanu O, Grumbine FC, Escobar PF. Laparoendoscopic Single Site Surgery in Gynecology: A Multi-Institutional Evaluation. Am J Obstet Gynecol. Nov 2009;203(5):501.e1-6.
25. Fader AN, Lesnock JL, Guido RS, Gold MA, Moore, KN. Cervical Dysplasia in Pregnancy: A Multi-Institutional Evaluation. Am J Obstet and Gynecol. 2010 Aug;203(2):113.e1-6.
26. Fader AN, Cohen S, Escobar PF, Gunderson C. Laparoendoscopic single-site surgery in gynecology. Curr Opin Obstet Gynecol. 2010 Aug;22(4):331-8
27. Escobar PF, Fader AN, Rasool N. Laparoendoscopic Single-Site Surgery (LESS) Pelvic and Para-aortic Lymphadnectomy: A Technique and Feasiblity Paper. Int J Gynecol Cancer. 2010 Oct;20(7):1268-73
28. Fader AN, Cohen S, Escobar PF, Gunderson C. Laparoendoscopic single-site surgery in gynecology. Curr Opin Obstet Gynecol. 2010 Aug;22(4):331-8
29. Fader AN, Rasool N, Vaziri SA, Kozuki T, Faber PW, Elson P, Biscotti CV, Michener CM, Rose PG, Rojas-Espaillat L, Belinson JL, Ganapathi MK, Ganapathi R CCL2 Expression in Ovarian Carcinoma is Associated with Chemosensitivity and Improved Survival Outcomes. Anticancer Res. 2010 Dec;30(12):4791-8
30. Skaznik-Wikiel M, Ueda S, Rose PG, Fleury A, Grumbine F, Fader AN. Cervical cytology in the preoperative diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer? Acta Cytol. April;2011;55(3):255-60
31. Ibeanu O, Modesitt S, Ducie J, von Gruenigen VE, Fader AN. Hormonal Therapy in Gynecologic Cancer Survivors: Why Not? Gynecol Oncol, 2011 Aug;122(2):447-54
32. Fader AN, Frasure HE, von Gruenigen VE. Quality of Life in Endometrial Cancer: What Does Obesity Have to Do With It? Obstet Gynecol Int. 2011;308609. Epub 2011 Oct 29.
33. Moxley KM, Fader AN, Rose PG, Case A, Mutch D, Berry E, Lurain J, Schink J, Moore KN, Malignant Melanoma of the Vulva: An Extension of Cutaneous Melanoma, Gynecol Oncol. Sept 2011;122(3):612-7.
34. Gunderson CC, Ritter C, Bedaiwy M, Hurd W, Grumbine FC, Fader AN. The risk of umbilical hernia and other complications with laparoendoscopic single-site surgery (LESS). J Min Inv Gynecol, 2012 Jan;19(1):40-5.
35. Dizon D, Blessing JA, Penson RT, Drake RD, Walker JL, Fader AN. A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol. 2012 May;125(2):367-71.
36. Escobar PF, Frumovitz M, Soliman PT, Frasure HE, Fader AN, Schmeler KM, Ramirez PT. Comparison of Single-Port Laparoscopy, Standard Laparoscopy, and Robotic Surgery in Patients with Endometrial Cancer. Ann Surg Oncol. 2012 May;19(5):1583-8.
37. Gunderson CC, Fader AN, Carson KT, Bristow RE. Conservative management of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma: A contemporary systematic review. Gynecol Onco., 2012 May;125(2):477-82.
38. Fader AN, Seamon LG, Frasure HE, Escobar PF, Secord AA, Cohn D, Fowler J, Boggess J, Rossi E, Havrilesky L, Gehrig PA. Minimally Invasive Surgery versus Laparotomy in Women with High Grade Endometrial Cancer: A Multi-Site Study Performed at High Volume Cancer Centers. Gynecol Oncol. 2012 Aug;126(2):180-5
39. Coleman R, Deavers M, Drescher, C, Fader AN, Gershenson D, Sood A. A Phase II Evaluation of Aflibercept in the Treatment of Recurrent or Advanced Endometrial Cancer: A Gynecologic Oncology Group Study. Gynecol Oncol, 2012 Aug 23. [Epub ahead of print].
40. Cantrell LA, Havrilesky L, Moore DT, OMalley DM, Liotta M, Secord AA, Fader AN, Cohn DM, Wallace A, Rose PG, Gehrig PA Comparative effectiveness of adjuvant therapy in early stage uterine carcinosarcoma. Gynecol Oncol. 2012 Oct;127(1):22-6
41. Fader AN, Winder A, Sandadi S, DeBernardo R. Sweets Syndrome: A Harbinger of Ovarian Carcinoma. J Gynecol Oncol, 2012 Oct;23(4):288-90
42. Tergas AI, Green I, S. Sheth, Giuntoli RL, Winder A, Fader AN. A Pilot Study of Surgical Training Utilizing a Virtual Reality Robotic Surgery Simulator. J Soc Laparoendoscopic Surg. In press, Feb 2013
43. Scheib S, Simpson K, Grumbine F, Fader AN. Laparoendoscopic Single-Site Surgery (LESS) in Pregnancy: A Case Series. In press, J Min Inv Gynecol, in press, Feb 2013
44. Jernigan AM, Tergas AI, Satin A, Fader AN. Obesity Management in Gynecologic Cancer Survivors: Provider Practices and Attitudes. In press, Am J Obstet Gynecol, Feb 6 2013, Epub: *Editors choice featured article with accompanying editorial by Paola Gehrig, MD
45. Tergas AI, Fader AN. Laparoendoscopic Single-Site Surgery (LESS) Radical Hysterectomy for the Treatment of Early Stage Cervical Cancer. Gynecol Oncol, Epub Dec 20, 2012
46. Sheth S, Fader AN, Tergas AI, Kushnir C, Green I. Virtual Reality Robotic Surgical Simulation: An Analysis of Gynecology Trainees. J Surg Educ, In press March 2013
Honors
- Association of Professor of Gynecology and Obstetrics (APGO) National Excellence in Teaching Award, Johns Hopkins Hospital
- Johns Hopkins Teaching and Mentorship Award, Department of Gynecology and Obstetrics, 1/1/12
- Young Doctors Summit Representative, International Gynecologic Cancer Society (IGCS), 1/1/12
- Appointed member, Society of Gynecologic Oncology (SGO) Council, 1/1/12
- CREOG National Teacher of the Year Award, Johns Hopkins Gynecology/Obstetrics Program, 1/1/11
- Best Paper in Minimally Invasive Gynecologic Oncology, American Association of Gynecologic Laparoscopy (AAGL) Annual Meeting, 11/1/10
- Teacher of the Year Award, Greater Baltimore Medical Center OB/GYN, 1/1/10
- AACR/ASCO Clinical Trials Workshop Grant, Vail, 8/1/08
- 1st prize, Cleveland Ob/Gyn Society Research Symposium, 1/1/08
- Research Fund Young Investigator Award, Gynecologic Oncology Group/Ovarian Cancer, 1/1/08
- GlaxoSmithKline $1800 Grant, SGO Winter Meeting; (invited for oral research presentation), 1/1/08
- Berlex Pharmaceuticals Award for Outstanding Ob/Gyn Resident Teacher, 1/1/04
- Outstanding 2nd Year Resident Teaching Award, 1/1/03
- Golden Apple Teaching Award, University of Pittsburgh School of Medicine, 1/1/02
- Humanism in Medicine and Teaching Award, The Arnold P. Gold Foundation, 1/1/02
- Medical Honor Society, Alpha Omega Alpha, 1/1/02
Locations
- Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
- 10753 Falls Road, Pavilion II Suite 245, Lutherville, MD 21093
- Get Directions
- phone: 443-997-0400
- fax: 410-367-3312
Expertise
Education
- Fellowship: Cleveland Clinic, Gynecologic Oncology, 2009
- Residency: University of Pittsburgh Medical Center, Obstetrics and Gynecology, 2006
- Medical Education: Virginia Commonwealth Univ School of Medicine, MD, 2002
- Medical Education: University of Nevada Reno School of Medicine, Transferred medical schools, 2000
Board Certifications
- Gynecologic Oncology: American Board of Obstetrics and Gynecology, 2012
- Obstetrics and Gynecology: American Board of Obstetrics and Gynecology, 2011
Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- Veteran Affairs Community Care Network (Optum-VACCN)
Ratings & Reviews
4.9 out of 5
146 ratings, 58 reviewsThe Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
- 5 out of 5 starsReviewed on 2/10/2026
Dr Fader was extremely kind patient and compassionate
- 5 out of 5 starsReviewed on 2/9/2026
I'm 100% happy with my provider.
- 5 out of 5 starsReviewed on 2/2/2026
Professional and patient.
- 5 out of 5 starsReviewed on 2/2/2026
Dr. Fader is in high demand because she's good at her job so she's very busy. So I understand the delays. She is excellent in her field.
- 5 out of 5 starsReviewed on 2/2/2026
The BEST GYN Ongologist ever kind caring
- 5 out of 5 starsReviewed on 1/13/2026
Dr Fader provided me will information and resources to enhance my recovery
- 5 out of 5 starsReviewed on 1/13/2026
She is very pleasant, listens and concerned with my issues/health
- 5 out of 5 starsReviewed on 1/12/2026
Dr Fader was my oncologist six years ago when she headed the Dept at JH. Because she was very busy, she asked if I would go to [staff] as my oncologist it she would be available to me. [staff] was wonderful, too, but he recently moved to a different position in Philadelphia. So he asked Dr Fader if I could return to her.
- 5 out of 5 starsReviewed on 1/12/2026
My provider very knowledgeable. Kind, explained what she did.
- 5 out of 5 starsReviewed on 12/22/2025
Exceptional physician. Kind and caring.
- 5 out of 5 starsReviewed on 12/15/2025
Very approachable, good listener and knowledgeable
- 5 out of 5 starsReviewed on 12/15/2025
Dr. Fader is exceptional. Totally happy being Under her care along with JohnsHopkins!!
- 5 out of 5 starsReviewed on 12/15/2025
I have a terminal illness so to have Dr. Fader be thoughtful, strategic, data-driven and collaborative while ALSO being caring, compassionate and empathetic is a blessing. She is very humble and definitely one of the best care providers I've ever worked with.
- 2 out of 5 starsReviewed on 12/15/2025
I had an appointment scheduled with Dr. Fader and was told upon arrival that they were running about 30 minutes behind. Unfortunately, I ended up waiting over an hour past my appointment time. While I understand that delays can happen, clearer communication and more accurate time estimates would have been appreciated. Long wait times can be very frustrating, especially when patients plan their day around scheduled appointments.
- 5 out of 5 starsReviewed on 12/8/2025
Dr. Fader spent time answering all my questions. I did not feel rushed.
- 5 out of 5 starsReviewed on 12/8/2025
First time meeting Dr. Fader she was very concerned and caring about my issue.
- 5 out of 5 starsReviewed on 12/8/2025
Dr. Fader is an amazing person. Made my mom and I feel comfortable and at ease with everything going on.
- 5 out of 5 starsReviewed on 12/1/2025
Excellent
- 5 out of 5 starsReviewed on 11/24/2025
Excellent doctors and nurse. Very knowledgeable, caring, and compassionate.
- 5 out of 5 starsReviewed on 11/24/2025
Dr Fader went above and beyond to give me clear answers to my questions and to explain the procedures, answered MyChart questions very quickly, and was generally calming and kind during a most stressful health event.
- 5 out of 5 starsReviewed on 11/24/2025
Second opinion and night and day from first provider I saw elsewhere. Thoughtful, wanted to know my goals and values up front, and I now have great info plus next steps. her resident and nurse were also excellent
- 5 out of 5 starsReviewed on 11/17/2025
Very knowledgeable, very caring.
- 5 out of 5 starsReviewed on 11/17/2025
Wonderful
- 5 out of 5 starsReviewed on 11/10/2025
Dr Amanda Fader is extremely kind, competent, knowledgeable, and helpful in guiding me in my cancer care.
- 5 out of 5 starsReviewed on 10/31/2025
Dr. Fader exhibited expertise and empathy during our visit with her. She helped us gain clarity for several areas of concern for us. She went out of her way to make us feel comfortable with her, as did her team. We could not ask for a better experience.
- 5 out of 5 starsReviewed on 10/27/2025
Dr. Fader was very kind and gave a very clear and helpful explanation of what I could expect. [staff] was also very kind and helpful.
- 5 out of 5 starsReviewed on 10/20/2025
Dr. Fader was very informative and has an excellent bedside manner.
- 5 out of 5 starsReviewed on 10/20/2025
She was extremely knowledgeable and easy to talk to!
- 5 out of 5 starsReviewed on 10/20/2025
Dr. Fader is outstanding
- 5 out of 5 starsReviewed on 10/20/2025
Dr Fader is very tuned in to my feelings and fears when I see her she is awesome
- 5 out of 5 starsReviewed on 10/14/2025
It was nice to meet Dr. Fader since my friend spoke of her often. She explained everything thoroughly.
- 5 out of 5 starsReviewed on 10/14/2025
Very caring and knowledgeable
- 5 out of 5 starsReviewed on 10/6/2025
Dr. Fader is absolutely the best!
- 5 out of 5 starsReviewed on 9/23/2025
I love this Doctor
- 5 out of 5 starsReviewed on 9/22/2025
Dr Fader is an excellent provider with great expertise in her area of care. What I especially appreciate about Dr Fader is how comfortable she makes you feel. She listens takes the time to explain diagnosis and treatment plan. Before and during examination, Dr Fader, continues to communicate and explain what she is doing. She values your dignity as the patient.
- 5 out of 5 starsReviewed on 9/15/2025
Great doctor
- 5 out of 5 starsReviewed on 9/15/2025
Dr Fader was a wonderful listener, seemed experienced and knowledgeable, and explained everything carefully.
- 5 out of 5 starsReviewed on 8/26/2025
Dr. Fader is excellent. I now travel over two hours to stay in her care, even though I have other options.
- 5 out of 5 starsReviewed on 8/25/2025
Dr. Fader was thorough, kind & compassionate.
- 5 out of 5 starsReviewed on 8/18/2025
I trust her with my life.
- 5 out of 5 starsReviewed on 8/12/2025
Dr. Fader is great! She explains things in detail and is very patient.
- 5 out of 5 starsReviewed on 7/28/2025
She is the best doctor ever. She is professional, knowledgeable and kind. She gives the facts with empathy. I was sad and scarred at the diagnosis of cancer, she confirmed my fears but promise to stand by me all the way during my recovery journey. This she did. She gave me confidence to fight the cancer. By God's grace and her support, I am cancer free and In remission after 9months. I survive chemotherapy and over 12 hours of surgery. As an oncology nurse myself, I have never seen any better Oncologist.
- 5 out of 5 starsReviewed on 7/22/2025
Dr. Was very thorough and helpful she referred me to much assistance needed. Along with understanding my condition and concerns.
- 5 out of 5 starsReviewed on 7/8/2025
Love her!
- 4 out of 5 starsReviewed on 7/7/2025
I had a new diagnosis and was given an immediate appointment. My provider was very thorough when going over my most recent procedures, labs, diagnostic reports etc.
- 5 out of 5 starsReviewed on 6/30/2025
Dr. Fader is very knowledgeable, and over the past year of my cancer battle, I also see her as caring and reassuring.
- 5 out of 5 starsReviewed on 6/9/2025
Excellent medical knowledge relevant toMy current condition , carrying
- 5 out of 5 starsReviewed on 6/2/2025
Dr. Nickles Fader is very knowledgeable and attentive answering all my questions. She told me she will follyup once the lab results come back
- 5 out of 5 starsReviewed on 6/2/2025
Dr. Fader is very compassionate and personable, I look forward to my visits to seeing her!
- 5 out of 5 starsReviewed on 6/2/2025
Very personable and patient focused toward my needs.
- 5 out of 5 starsReviewed on 5/27/2025
Dr. Fader is AMAZING, she's respectful and responds to all my concerns.
- 5 out of 5 starsReviewed on 5/20/2025
Dr. Fader saved my life back in 3018, and is helping me navigate/treat a recurrence of my stage 4 ovarian cancer. I truly believe I would not be here without her.
- 5 out of 5 starsReviewed on 5/13/2025
Dr Fader is the absolute best doctor and surgeon, and without her, I would not be here today.
- 5 out of 5 starsReviewed on 5/13/2025
She has saved my life twice
- 5 out of 5 starsReviewed on 5/5/2025
Very productive visit.
- 5 out of 5 starsReviewed on 4/28/2025
Best provider ever.
- 5 out of 5 starsReviewed on 4/28/2025
Excellent bedside manners. Very compassionate
- 5 out of 5 starsReviewed on 4/22/2025
Dr. Fader has been my oncologist since 2019. I trust her implicitly. I appreciate her professionalism and sincere empathy.